Switching from nurse-administered to patient self-administration of medications in hospitals
Evaluation of the Safety of a Change of Practice in the Administration of Oral Medication During Hospitalisation: From Administration by the Nurse to Supervision of Self-administration of Medication in the Locomotor and Polyvalent Rehabilitation Department of the Valenciennes Hospital Centre.
This study tests if letting patients in rehab take their own medications instead of having nurses give them can help them feel more in control and understand their medicine better.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 192 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Centre Hospitalier de Valenciennes Research network |
| Locations | 1 site (Valenciennes) |
| Trial ID | NCT06639113 on ClinicalTrials.gov |
What this trial studies
This study evaluates the impact of allowing patients in a rehabilitation unit to self-administer their medications instead of having nurses administer them. The goal is to enhance patient autonomy and improve their understanding and compliance with their medication regimens. By transitioning to a self-administration program, the study aims to assess the safety and effectiveness of this approach during hospital stays. The research is particularly focused on patients who are already accustomed to managing their medications at home.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older who are in a rehabilitation unit and have a planned hospital stay of 7 days or more while on chronic medication.
Not a fit: Patients with unstable diseases, significant cognitive impairments, or those under legal protection may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could lead to improved patient autonomy and safety in medication administration during hospital stays.
How similar studies have performed: While there have been studies on self-administration of medications in other countries, this specific approach has not been extensively tested in France.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Care in the rehabilitation unit of Hospital in Valenciennes, France * Patient with a planned stay of 7 days or more * Patient on chronic treatment before admission to hospital ; * Patients taking their treatment alone at home; Exclusion Criteria: * Age \< 18 years old * Patients with poor compliance * No chronic treatment * Unstable disease * Major cognitive, memory or depressive disorders * Swallowing disorders * Prehension problems * Patient under legal protection * Patient under guardianship or curatorship * Patient included in another trial
Where this trial is running
Valenciennes
- CH Valenciennes — Valenciennes, France (Recruiting)
Study contacts
- Principal investigator: Quentin HIVER, PH — Centre Hospitalier de Valenciennes
- Study coordinator: Quentin HIVER
- Email: hiver-q@ch-valenciennes.fr
- Phone: 0327143333
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.